San Francisco, CA12 days ago
You will lead biomarker design and execution for key programs, oversee advanced translational assays in both preclinical models and human samples, and partner closely with discovery, clinical, data science, and external collaborators to deliver high-quality biomarker data. PhD and 10+ years, or MS and 13+ years, of relevant industry-focused experience in immune-oncology, immunology, or a closely related field, including drug and biomarker development from preclinical through Ph1–3 clinical stages.